Clinical Trials on Exudative Age-related Macular Degeneration

Total 6461 results

Amore Filippo

Completed

MP-3 Biofeedback Training and Central Vision Loss

Age-Related Macular Degeneration

Italy
OKKO Health
Nottingham University Hospitals NHS Trust; Oxford University Hospitals NHS... and other collaborators

Enrolling by invitation

Patient-centred Smartphone AI for Protecting Vision in Macular Disease

Age-Related Macular Degeneration

United Kingdom
Notal Vision Inc.

Active, not recruiting

ForeseeHome NRich Registry

Age-Related Macular Degeneration

United States
Novartis Pharmaceuticals

Terminated

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections (MERLIN)

Age-Related Macular Degeneration

United States, Puerto Rico
Stanford University

Completed

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

Age-Related Macular Degeneration

United States
Kubota Vision Inc.

Completed

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Age Related Macular Degeneration

United States
Centre Hospitalier Intercommunal Creteil

Completed

Patient's Feelings After Receiving a Diagnosis of Age-related Macular Degeneration (PANDA)

Age Related Macular Degeneration

France
Shahid Beheshti University of Medical Sciences

Unknown

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Age Related Macular Degeneration

Iran, Islamic Republic of
University Hospital of Ferrara
Regione Emilia-Romagna

Completed

Single or Combined Protocols for NV-AMD

Age-Related Macular Degeneration
Brugmann University Hospital

Completed

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Age-Related Macular Degeneration

Belgium
Lawson Health Research Institute
The Physicians' Services Incorporated Foundation; Academic Health Science Centres

Completed

Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes

Age Related Macular Degeneration

Canada
Ulucanlar Eye Training and Research Hospital

Completed

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

Age Related Macular Degeneration
Astellas Institute for Regenerative Medicine

Withdrawn

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (PORTRAY)

Age-Related Macular Degeneration

United States
Oxford BioMedica

Completed

Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) (GEM)

Age Related Macular Degeneration

United States
University Hospital Hradec Kralove

Unknown

Treatment of AMD With Rheohemapheresis /RHF/ (TARHF)

Age Related Macular Degeneration

Czech Republic
Catholic University of the Sacred Heart

Unknown

Effect of Saffron Supplementation on Macular Cone-mediated Function in Age-related Macular Degeneration (safAMD)

Age-Related Macular Degeneration

Italy
Notal Vision Ltd.

Completed

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

HMP (Home Macular Perimeter) -Usability Trial

Age Related Macular Degeneration
Forsight Vision4

Completed

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

Latvia
Medical University of Vienna

Terminated

Macular Pigment Optical Density in Healthy Subjects

Age Related Macular Degeneration

Austria
Johns Hopkins University
Alimera Sciences; pSiVida Limited

Completed

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot (MAP)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Usage of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients (UU2)

Age Related Macular Degeneration

Israel
Paloma Pharmaceuticals, Inc.

Completed

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration (P52901)

Age-Related Macular Degeneration

United States
Russian Academy of Medical Sciences

Unknown

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

Russian Federation
University of Malaya

Unknown

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

Age Related Macular Degeneration

Malaysia
Lawson Health Research Institute
St. Joseph's Healthcare Foundation

Completed

Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora

Age-Related Macular Degeneration

Canada
Oregon Health and Science University
Genentech, Inc.

Completed

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Usability Study (AMD)

Age Related Macular Degeneration
National Eye Institute (NEI)
QLT Inc.

Terminated

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration (VERTACL)

Age-Related Macular Degeneration

United States
Royal Liverpool University Hospital

Unknown

Macular Function During Anti-VEGF Treatment (MAFAT)

Age Related Macular Degeneration

United Kingdom
University Health Network, Toronto

Completed

Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration

Age-Related Macular Degeneration

Canada
MacuCLEAR, Inc.

Terminated

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

Nonexudative Age Related Macular Degeneration

United States
Perceive Biotherapeutics, Inc.

Recruiting

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

Australia, Israel
Benobio Co., Ltd.

Not yet recruiting

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

Australia
The University of Hong Kong

Recruiting

Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Age-Related Macular Degeneration

Hong Kong
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

China
OKKO Health

Recruiting

OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration

Age-Related Macular Degeneration

United Kingdom
OcuDyne, Inc.

Recruiting

OcuDyne System in the Treatment of AMD

Age-Related Macular Degeneration

Argentina
Icahn School of Medicine at Mount Sinai
University of California, Los Angeles; National Eye Institute (NEI)

Recruiting

Snapshot Camera for AMD

Age Related Macular Degeneration

United States
National Eye Institute (NEI)

Recruiting

Dark Adaptation in Participants With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Medical University of Vienna

Recruiting

Non-invasive Optical Angiography in Age-related Macular Degeneration

Age Related Macular Degeneration

Austria
Medical University of Vienna

Recruiting

The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Subjects

Age-Related Macular Degeneration

Austria
National Eye Institute (NEI)

Recruiting

Study of Dark Adaptation in Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Oxford BioMedica

Active, not recruiting

A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Duke University
Genentech, Inc.

Completed

AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study (A2ASDOCT)

Age Related Macular Degeneration

United States
University Hospital Inselspital, Berne

Active, not recruiting

The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)

Age Related Macular Degeneration

Switzerland

Clinical Trials on Exudative Age-related Macular Degeneration

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations